Evidence map›Paper›PMID 32037950›Full record

ArticleGut microbes2020

Oral antibiotic use and chronic disease: long-term health impact beyond antimicrobial resistance and

Jessica Queen, Jiajia Zhang, Cynthia L Sears

Abstract read
In one paragraph

Article in Gut microbes, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Trial
  2. Gut microbes · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Inactivation of glutathioneGut microbes · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. New insights into the treatment of acute otitis media.Expert review of anti-infective therapy · 2023
    Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jessica QueenDivision of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine , Baltimore, MD, USA.
Jiajia ZhangThe Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine , Baltimore, MD, USA.
Cynthia L SearsDivision of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine , Baltimore, MD, USA.ORCID 0000-0003-4059-1661

Funding

Translational Research Enhancement CoreP30DK089502 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI ZACHOS, NICHOLAS CONSTANTINE · 2011 to 2020
$12.0M
RESEARCH TRAINING IN MICROBIAL DISEASEST32AI007291 · NIAID · JOHNS HOPKINS UNIVERSITY · PI JOEL N BLANKSON, Sara Elizabeth Cosgrove · 1986 to 2026
$9.1M
Cancer Research UKNIAID NIH HHS T32 AI007291NIDDK NIH HHS P30 DK089502
6 · The paper itself

Abstract

We recently reported an increased colon cancer risk associated with oral antibiotic use in a large United Kingdom population. This association between antibiotic exposure and cancer risk adds to a growing body of evidence that antibiotic use has unintended off-target long-term health consequences. This addendum highlights major studies linking antibiotic use and chronic disease in pediatric and adult populations. Microbiota dysbiosis is the key proposed mechanism underlying antibiotic:disease associations, resulting in alterations in gene expression, epigenetic modification, colonization by pathogenic bacteria, instigation of biofilms, and immune regulation and inflammation. These adverse outcomes of antibiotic exposure underscore the need for diagnostic and antibiotic stewardship, as well as the urgency for further development of non-antibiotic therapies for bacterial infections.

Indexed as

Drug UtilizationAdministration, OralAdolescentAdultAgedAnti-Bacterial AgentsAntimicrobial StewardshipBacteriaBacterial InfectionsChildChronic DiseaseClostridioides difficileClostridium InfectionsColonic NeoplasmsDrug Resistance, BacterialDysbiosisAnti-Bacterial Agentsantibioticsantibiotic stewardshipcancer riskcarcinogenesisColorectal cancermicrobiota dysbiosis

Identifiers

PMID32037950
PMCPMC7524332

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.